1-Methylimidazolidin-2-one → HCID 71251874, compound
Reaction equation
[CH3:1][N:2]1[CH2:6][CH2:5][NH:4][C:3]1=[O:7].Br[C:9]1[CH:10]=[CH:11][C:12]([C:15]([N:17]2[CH2:22][CH2:21][N:20]([C:23]3[CH:28]=[CH:27][C:26]([CH3:29])=[CH:25][C:24]=3[CH3:30])[CH2:19][CH2:18]2)=[O:16])=[N:13][CH:14]=1>>[CH3:30][C:24]1[CH:25]=[C:26]([CH3:29])[CH:27]=[CH:28][C:23]=1[N:20]1[CH2:21][CH2:22][N:17]([C:15]([C:12]2[N:13]=[CH:14][C:9]([N:4]3[CH2:5][CH2:6][N:2]([CH3:1])[C:3]3=[O:7])=[CH:10][CH:11]=2)=[O:16])[CH2:18][CH2:19]1Participants
3
Procedure
Using 1-methyl-2-imidazolidinone (37 mg) and (5-bromopyridin-2-yl)[4-(2,4-dimethylphenyl)piperazin-1-yl]methanone (140 mg) described in Preparation Example 137 and by the reaction and treatment in the same manner as in Example 1, the title compound (78 mg) was obtained.
Workup
- customdescribed in Preparation Example 137 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-8c1250d23a19427b917b9a622b0e2327
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…